DENTSPLY SIRONA Inc (NASDAQ:XRAY) Shares Bought by Nomura Asset Management Co. Ltd.

Share on StockTwits

Nomura Asset Management Co. Ltd. grew its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 10.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 39,505 shares of the medical instruments supplier’s stock after acquiring an additional 3,731 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in DENTSPLY SIRONA were worth $1,987,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Generation Investment Management LLP boosted its holdings in DENTSPLY SIRONA by 115.6% in the 4th quarter. Generation Investment Management LLP now owns 9,011,670 shares of the medical instruments supplier’s stock worth $593,238,000 after acquiring an additional 4,831,112 shares during the period. Veritas Asset Management LLP lifted its stake in DENTSPLY SIRONA by 37.2% during the first quarter. Veritas Asset Management LLP now owns 8,417,655 shares of the medical instruments supplier’s stock worth $423,492,000 after purchasing an additional 2,281,200 shares during the last quarter. Viking Global Investors LP lifted its stake in DENTSPLY SIRONA by 51.9% during the fourth quarter. Viking Global Investors LP now owns 5,397,707 shares of the medical instruments supplier’s stock worth $355,331,000 after purchasing an additional 1,844,190 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in DENTSPLY SIRONA by 29.2% during the fourth quarter. Bank of New York Mellon Corp now owns 2,998,159 shares of the medical instruments supplier’s stock worth $197,370,000 after purchasing an additional 676,932 shares during the last quarter. Finally, Jackson Square Partners LLC lifted its stake in DENTSPLY SIRONA by 8.8% during the fourth quarter. Jackson Square Partners LLC now owns 6,891,530 shares of the medical instruments supplier’s stock worth $453,669,000 after purchasing an additional 556,624 shares during the last quarter. 93.81% of the stock is owned by institutional investors.

In related news, CFO Nicholas W. Alexos bought 50,000 shares of the stock in a transaction that occurred on Wednesday, May 9th. The stock was acquired at an average cost of $44.71 per share, with a total value of $2,235,500.00. Following the transaction, the chief financial officer now directly owns 25,411 shares in the company, valued at $1,136,125.81. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael J. Coleman sold 6,038 shares of DENTSPLY SIRONA stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $43.97, for a total value of $265,490.86. Following the completion of the transaction, the director now directly owns 26,960 shares of the company’s stock, valued at $1,185,431.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 7,856 shares of company stock worth $349,153. 1.93% of the stock is owned by corporate insiders.

A number of brokerages have recently commented on XRAY. Barclays reissued a “hold” rating and set a $55.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, May 8th. ValuEngine lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Robert W. Baird cut their price target on DENTSPLY SIRONA to $71.00 and set an “outperform” rating for the company in a research note on Tuesday, May 8th. Zacks Investment Research raised DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research note on Wednesday, June 6th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $57.00 price target (down from $67.00) on shares of DENTSPLY SIRONA in a research report on Tuesday, May 8th. Two analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $62.23.

DENTSPLY SIRONA opened at $43.77 on Friday, Marketbeat.com reports. DENTSPLY SIRONA Inc has a fifty-two week low of $41.64 and a fifty-two week high of $68.98. The company has a quick ratio of 1.46, a current ratio of 2.23 and a debt-to-equity ratio of 0.25. The stock has a market cap of $9.93 billion, a PE ratio of 16.66, a PEG ratio of 2.26 and a beta of 1.23.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Sunday, May 6th. The medical instruments supplier reported $0.45 EPS for the quarter, beating the consensus estimate of $0.42 by $0.03. The firm had revenue of $956.10 million during the quarter, compared to analysts’ expectations of $942.20 million. DENTSPLY SIRONA had a positive return on equity of 8.63% and a negative net margin of 38.32%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 earnings per share. equities research analysts anticipate that DENTSPLY SIRONA Inc will post 2.57 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 12th. Stockholders of record on Friday, September 28th will be paid a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.80%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently 13.16%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply